BioInvent International Aktiebolag (BINV): key financial figures for fiscal year 2025 (in SEK), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025): kr 226.5M
Net Income/Loss (FY2025): -kr 332.9M
Total Assets (FY2025): kr 671.2M
Total Equity (FY2025): kr 557.6M
Cash Flows from Operating Activities (FY2025): -kr 247.8M

Source: BioInvent International Aktiebolag annual_report filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.

BioInvent International Aktiebolag (BINV): key financial figures for fiscal year 2025 (in SEK), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025): kr 226.5M
Net Income/Loss (FY2025): -kr 332.9M
Total Assets (FY2025): kr 671.2M
Total Equity (FY2025): kr 557.6M
Cash Flows from Operating Activities (FY2025): -kr 247.8M

Source: BioInvent International Aktiebolag annual_report filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.